Exact Mass: 524.2765
Exact Mass Matches: 524.2765
Found 194 metabolites which its exact mass value is equals to given mass value 524.2765
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methyl (2-((R)-(3-chlorophenyl)((R)-1-(((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propyl)carbamoyl)piperidin-3-yl)methoxy)ethyl)carbamate
Falecalcitriol
Sucrose laurate
Sucrose monolaurate
Sucrose, 1-laurate
Okaramine C
An indole alkaloid isolated from Penicillium simplicissimum. It exhibits insecticidal activity.
2alpha-acetyloxy-4beta-hydroxy-6alpha-angeloyloxy-10beta-cinnamoyloxydauc-8-ene|2??-Acetoxy-4??-hydroxy-6??-angeloyloxy-10??-cinnamoyloxy-dauc-8-ene
13alpha-acetoxy-5-alpha-cinnamoyloxy-11(15-1)abeotaxa-4(20),11-diene-9alpha,10beta,15-triol
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxopentan-2-yl] 2-hydroxy-3-methylpentanoate
C31H40O7_3,9-Diacetoxy-2,6,6,13-tetramethyl-12-oxotetracyclo[11.2.1.0~1,10~.0~2,7~]hexadec-8-yl benzoate
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxopentan-2-yl] 2-hydroxy-3-methylpentanoate [IIN-based on: CCMSLIB00000846977]
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxopentan-2-yl] 2-hydroxy-3-methylpentanoate [IIN-based: Match]
Cys Phe Lys Lys
Cys Lys Phe Lys
Cys Lys Lys Phe
Phe Cys Lys Lys
Phe Lys Cys Lys
Phe Lys Lys Cys
His Ile Gln Gln
His Leu Gln Gln
His Asn Arg Val
His Asn Val Arg
His Gln Ile Gln
His Gln Leu Gln
His Gln Gln Ile
His Gln Gln Leu
His Arg Asn Val
His Arg Val Asn
His Val Asn Arg
His Val Arg Asn
Ile His Gln Gln
Ile Met Val Tyr
Ile Met Tyr Val
Ile Gln His Gln
Ile Gln Gln His
Ile Val Met Tyr
Ile Val Tyr Met
Ile Tyr Met Val
Ile Tyr Val Met
Lys Cys Phe Lys
Lys Cys Lys Phe
Lys Phe Cys Lys
Lys Phe Lys Cys
Lys Lys Cys Phe
Lys Lys Phe Cys
Leu His Gln Gln
Leu Met Val Tyr
Leu Met Tyr Val
Leu Gln His Gln
Leu Gln Gln His
Leu Val Met Tyr
Leu Val Tyr Met
Leu Tyr Met Val
Leu Tyr Val Met
Met Ile Val Tyr
Met Ile Tyr Val
Met Leu Val Tyr
Met Leu Tyr Val
Met Val Ile Tyr
Met Val Leu Tyr
Met Val Tyr Ile
Met Val Tyr Leu
Met Tyr Ile Val
Met Tyr Leu Val
Met Tyr Val Ile
Met Tyr Val Leu
Asn His Arg Val
Asn His Val Arg
Asn Arg His Val
Asn Arg Val His
Asn Val His Arg
Asn Val Arg His
Gln His Ile Gln
Gln His Leu Gln
Gln His Gln Ile
Gln His Gln Leu
Gln Ile His Gln
Gln Ile Gln His
Gln Leu His Gln
Gln Leu Gln His
Gln Gln His Ile
Gln Gln His Leu
Gln Gln Ile His
Gln Gln Leu His
Arg His Asn Val
Arg His Val Asn
Arg Asn His Val
Arg Asn Val His
Arg Val His Asn
Arg Val Asn His
Val His Asn Arg
Val His Arg Asn
Val Ile Met Tyr
Val Ile Tyr Met
Val Leu Met Tyr
Val Leu Tyr Met
Val Met Ile Tyr
Val Met Leu Tyr
Val Met Tyr Ile
Val Met Tyr Leu
Val Asn His Arg
Val Asn Arg His
Val Arg His Asn
Val Arg Asn His
Val Tyr Ile Met
Val Tyr Leu Met
Val Tyr Met Ile
Val Tyr Met Leu
Tyr Ile Met Val
Tyr Ile Val Met
Tyr Leu Met Val
Tyr Leu Val Met
Tyr Met Ile Val
Tyr Met Leu Val
Tyr Met Val Ile
Tyr Met Val Leu
Tyr Val Ile Met
Tyr Val Leu Met
Tyr Val Met Ile
Tyr Val Met Leu
(5Z,7E)-(1S,3R)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
(5Z,7E)-(1S,3R)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
3,9-Diacetoxy-2,6,6,13-tetramethyl-12-oxotetracyclo[11.2.1.01,10.02,7]hexadec-8-yl benzoate
26,26,26,27,27,27-hexafluoro-1alpha,24-dihydroxyvitamin D3
26,26,26,27,27,27-hexafluoro-1alpha,25-dihydroxyvitamin D3
VTP-27999
2-(methylthio)-4,6-bis(N-tert-butyloxy-carbonyl-piperidin-4-yloxy)pyrimidine
alpha-d-Glucopyranoside, beta-d-fructofuranosyl, dodecanoate
Falecalcitriol
D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D003879 - Dermatologic Agents
(5Z)-5-[(2E)-2-[7a-methyl-1-[7,7,7-trifluoro-6-hydroxy-6-(trifluoromethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphoethanolamine(1-)
(3S)-3beta-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-6-(1,1-dimethyl-2-propenyl)-2,3,4,5aalpha,6,10b,11,11aalpha-octahydro-10balpha-hydroxy-1H-pyrazino[1,2:1,5]pyrrolo[2,3-b]indole-1,4-dione
[3-Methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxopentan-2-yl] 2-hydroxy-3-methylpentanoate
3-cyclohexyl-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-9-(methanesulfonamido)-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-9-(methanesulfonamido)-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
3-cyclohexyl-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-9-(methanesulfonamido)-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methylurea
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-hexadec-9-enoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tetradec-9-enoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-tridec-9-enoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-pentadec-9-enoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate
BIBS 39
BIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist. Target: Angiotensin Receptor in vitro: BIBS 39 displaces [125I] AII from its specific binding sites with a Ki value of 29 ± 7 nM for the AII subtype 1 (AT1) receptor and a Ki value of 480 ± 110 nM for the AII subtype 2 (AT2) receptor. BIBS 222 shows a Ki value of 20 ± 7 nM for the AT1 subtype and a Ki value of 730 ± 170 nM for the AT2 subtype. BIBS 39 is 17 times more selective for the AT1 subtype and BIBS 222 37 times. BIBS 39 shifts the AII concentration-contractile response curves in isolated rabbit aorta to the right in a parallel fashion. [1] in vivo: In pithed rats, BIBS 39 dependently shifts the dose-response curve of AII to the right without affecting the maximal response. BIBS 222 also causes parallel shifts to the right but a significant reduction of the maximal responses was observed at 3 and 10 mg/kg i.v. These results show that the benzimidazole derivatives BIBS 39 is a potent and selective AII receptor antagonists. Substitution with a benzimidazole moiety results into a considerable loss of selectivity for the AT1 receptor subtype compared with an imidazole moiety as, for instance, in DuP 753.[1] BIBS 39 is a new nonpeptide angiotensin receptor blockers that has affinity for both AT1- and AT2-receptors, is also a potent antagonist of the cardiovascular effects of AII in pithed rabbits. [2]
(2r,3s,4e)-4-[(3r,4e,8z)-3-hydroxy-10-{[(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl]oxy}-4,8-dimethyldeca-4,8-dien-1-ylidene]-2-(2-methylprop-1-en-1-yl)-5-oxooxolan-3-yl acetate
2-[(4-{4-hydroxy-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]butyl}-3,3,5-trimethylcyclohexyl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
2α-acetoxy-4β-hydroxy-6α-angeloyloxy-10β-cinnamoyloxy-dauc-8-ene
{"Ingredient_id": "HBIN005266","Ingredient_name": "2\u03b1-acetoxy-4\u03b2-hydroxy-6\u03b1-angeloyloxy-10\u03b2-cinnamoyloxy-dauc-8-ene","Alias": "NA","Ingredient_formula": "C31H40O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "208","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}